An observational study in Stroke, sponsored by Tan Tock Seng Hospital. Completed at 1 site in Singapore. Open to participants aged 21 Years to 90 Years. Per ClinicalTrials.gov, last updated 2023-09-21.
Sponsored by Tan Tock Seng Hospital · Observational
Hemiparetic weakness is common after stroke and only a small group of patients achieve useful upper limb function despite best rehabilitation efforts. This is due to the lack of intensive upper limb therapies to drive neuroplasticity either in clinic or at home.
In this study, we plan to pilot home-based, robot-aided-therapy using H-man to deliver intensive arm rehabilitation.
It has been assumed that stroke survivors reach a plateau in their recovery within 3-6 months of their stroke. They tend to receive minimal rehabilitation support once they are discharged to the community citing obstacles such as ambulation, transportation, and cost.
H-man is a novel telerehabilitation, upper limb training robot, that will deliver robot-aided therapy in patients' homes by clinic-based therapists through remote monitoring and under the supervision of their caregivers.
The study aims to refine and evaluate the feasibility, efficacy and safety of home-based training using the H-man robot.
7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.
This study's enrollment of 12 is below the median of 160 across 1,692 observational studies indexed under Stroke.
Browse Stroke studies →Tan Tock Seng Hospital is the lead sponsor of 103 studies on the registry; 17 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients in outpatient clinics
Exclusion Criteria:
(6) Hemi anaesthesia of affected limb (7) Severe visual impairment or visual neglect affecting ability to use H-Man robot (8) History of dementia, severe depression or behavioural problems (9) Pregnant or lactating females will not be allowed to participate (10) Absence of reliable carer to provide supervision during home training.
H-Man device will be deployed to patients for onboarding and home-based training.
Fugl Meyer Motor Assessment
Change in Fugl Meyer Motor Assessment score in the affected arm
Time frame: Assessed at week 5 from baseline (week 0)
Aggregated number
Mean/day and total cumulative over 30 days H-Man robot recorded arm repetitions (robotic metrics)
Time frame: Assessed at weeks 0, 5, 12 and 24
Streamlined Wolf-motor function test (SWMFT)
Functional score for stroke patients, minimum 0, maximum 75; with higher score indicating better function
Time frame: Assessed at weeks 0, 5, 12 and 24
Action Research Arm Test (ARAT)
Functional and dexterity score for upper extremities, minimum 0, maximum 57; with higher score indicating better function
Time frame: Assessed at weeks 0, 5, 12 and 24
Grip strength (KgF) measured by Digital Dynamometer (mean of 3 readings will be recorded)
Measured by Digital Dynamometer (mean of 3 readings will be recorded)
Time frame: Assessed at weeks 0, 5, 12 and 24
Self-efficacy outcomes by UPSET (upper limb self-efficacy test)
Questionnaire to measure self-efficacy in various tasks after stroke
Time frame: Assessed at weeks 0, 5, 12 and 24
HrQOL scales using SS-QOL (Stroke specific Quality of Life scale)
Quality of life scale specific to stroke patients, minimum 49, maximum 245; with higher scores indicating better function
Time frame: Assessed at weeks 0, 5, 12 and 24
PROMs using subjective scales (Likert 0-5) to questions
E.g. how beneficial, how comfortable, how useful, how easy was H-Man robot training experience at home, and would they prefer this to be part of standard therapy.
Time frame: Assessed at weeks 0, 5, 12 and 24
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tan Tock Seng Hospital